## EME: EMCOR Group, Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 1.32 indicates fundamental undervaluation. Quality metrics strong (ROE 37%, ROA 12%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-1.6% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($578.22)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.00M) |
| Sells | 1 ($0.90M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+17.6%)
- Blackrock Inc.: 8.7% (-24.0%)
- FMR, LLC: 5.9% (+29.1%)
- State Street Corpora: 4.1% (+15.2%)
- Geode Capital Manage: 3.2% (+36.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.32 suggests fair value with growth premium. Forward P/E 22.4x stretched relative to 9% growth. Quality metrics strong (ROE 37%, ROA 12%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.8B |
| Beta | 1.17 |
| 52W Range | $320.89 - $778.64 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.32 |
| Forward P/E | 22.4 |
| Current P/E | 24.5 |
| YoY Growth | 9.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.7% to 0.1% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.9pp (needs >4.0% for momentum thesis). MRS_5 (-0.0%) diverging from MRS_20 - short-term weakness emerging. MACD histogram positive (1.19), confirming momentum. RSI neutral at 49. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.09% (CS: 48) | Neutral |
| RSI_14 | 49.1 | Neutral |
| MACD Histogram | 1.19 | Bullish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 0.961x | Below |
| vs SMA200 | 1.130x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $621.82
- **Stop Loss:** $578.22 (7.0% risk)
- **Target:** $709.02 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $12,436.40
- **Portfolio %:** 12.44%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-25 (Est: $6.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.53 | $6.57 | +0.6% |
| 2025Q2 | $5.72 | $6.72 | +17.4% |
| 2025Q1 | $4.62 | $5.41 | +17.0% |
| 2024Q4 | $5.76 | $6.32 | +9.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*